Tectonic Therapeutic (TECX) Other financing activities (2018 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Other financing activities of $100000.0 for Q1 2026, down 99.94% year-over-year from $177.3 million in Q1 2025, and up 102.4% quarter-over-quarter from -$4.2 million in Q2 2025.
Powered by 
Analysis
Tectonic Therapeutic (TECX) Other financing activities (2018 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Other financing activities for 9 consecutive years, with $100000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other financing activities fell 99.94% year-over-year to $100000.0; the TTM figure through Mar 2026 stood at -$4.1 million (down 102.27% YoY), while the FY2025 annual figure was $173.1 million, up 10558.74% from the prior year.
- Other financing activities rose to $100000.0 in Q1 2026 per TECX's latest filing, from -$4.2 million in the prior quarter.
- Across five years, Other financing activities topped out at $177.3 million in Q1 2025 and bottomed at -$4.2 million in Q2 2025.
- Historically, Other financing activities has averaged $22.0 million across 5 years, with a median of $110000.0 in 2023.
- Annual changes were most pronounced in 2024 — Other financing activities jumped 1253.33% — and 2025, when it tumbled 795.0%.
- Tectonic Therapeutic's Other financing activities stood at $58000.0 in 2022, then soared by 106.9% to $120000.0 in 2023, then surged by 1253.33% to $1.6 million in 2024, then sank by 356.77% to -$4.2 million in 2025, then surged by 102.4% to $100000.0 in 2026.
- Business Quant data shows TECX's Other financing activities at $100000.0 in Q1 2026, -$4.2 million in Q2 2025, and $177.3 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Tectonic Therapeutic | 589.02 Mn | 589.02 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.81 Mn |
| Mar 31, 2026 | 1.26 Mn |
| Jun 30, 2025 | -4.17 Mn |
| Mar 31, 2025 | 177.27 Mn |
| Dec 31, 2024 | 899,000.00 |
| Sep 30, 2024 | 77,000.00 |
| Jun 30, 2024 | 600,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Dec 31, 2023 | 120,000.00 |
| Mar 31, 2023 | 42,000.00 |
| Dec 31, 2022 | 58,000.00 |
| Dec 31, 2021 | 48,000.00 |
| Sep 30, 2021 | 22,000.00 |
| Mar 31, 2021 | 850,000.00 |
| Dec 31, 2020 | 114,000.00 |
| Sep 30, 2020 | 60,000.00 |
| Jun 30, 2020 | 61,000.00 |
| Mar 31, 2020 | 35,000.00 |
| Dec 31, 2019 | 3,000.00 |
| Sep 30, 2019 | 9,000.00 |